In a similar vein, glial fibrillary acidic protein (GFAP)—an intermediate filament protein primarily expressed by astrocytes in the CNS—has been widely employed as a biomarker of astroglial activation and CNS injury in various neurological diseases [19]. The gene discussed is GFAP; the disease is nervous system disorder.